Quickstart Highlights
Cagrilintide + Semaglutide (10mg blend) dosage protocol offers a once-weekly subcutaneous injection approach aimed at supporting weight management and glycemic control.
- Gradual escalation from 0.25 mg up to 2.4 mg weekly
- Helps reduce appetite and improve metabolic markers
- Once-weekly injections for simplified scheduling
- Reconstitute with up to 3 mL for practical dosing
- Lyophilized vials should be stored in the freezer; refrigerate after mixing
Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL ≈ 3.33 mg/mL)
| Week | Weekly Dosage (mg) | Units (per injection) |
|---|---|---|
| Weeks 1–4 | 0.25 mg | ~7.5 units |
| Weeks 5–8 | 0.5 mg | ~15 units |
| Weeks 9–12 | 1.0 mg | ~30 units |
| Weeks 13–16 | 1.7 mg | ~51 units |
| Week 17+ (Maintenance) | 2.4 mg | ~72 units |
| Week | Weekly Dosage (mg) | Units (per injection) |
|---|---|---|
| Weeks 1–4 | 0.25 mg | ~7.5 units |
| Weeks 5–8 | 0.5 mg | ~15 units |
| Weeks 9–12 | 1.0 mg | ~30 units |
| Weeks 13–16 | 1.7 mg | ~51 units |
| Week 17+ (Maintenance) | 2.4 mg | ~72 units |
This schedule gradually escalates from 0.25 mg up to a 2.4 mg weekly maintenance dose. Reconstitute with 3 mL of bacteriostatic water for a ~3.33 mg/mL solution. Note that 0.25 mg (~7.5 units) may require a smaller insulin syringe for more precise measurement.
- Draw 3.0 mL of bacteriostatic water using a sterile syringe.
- Slowly inject the water along the vial wall to minimize foaming.
- Gently swirl—avoid vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Advanced / Aggressive Approach (3 mL ≈ 3.33 mg/mL)
| Week | Weekly Dosage (mg) | Units (per injection) |
|---|---|---|
| Weeks 1–2 | 0.5 mg | ~15 units |
| Weeks 3–6 | 1.0 mg | ~30 units |
| Weeks 7–10 | 1.7 mg | ~51 units |
| Weeks 11–16 (Maintenance) | 2.4 mg | ~72 units |
This faster escalation begins at 0.5 mg, reaching 2.4 mg by Week 11. Reconstitute with 3 mL for a ~3.33 mg/mL solution. For doses under 10 units, consider using a smaller insulin syringe for accurate measurements.
- Draw 3.0 mL of bacteriostatic water into a sterile syringe.
- Slowly inject the water to minimize foam formation.
- Gently roll or swirl the vial—no vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Supplies Needed
Ensure you have these on hand for an 8–16 week cycle.
- Peptide Vials (Product ID 10918):
• 8 wks ≈ 1 vial
• 12 wks ≈ 2 vials
• 16 wks ≈ 3 vials
(Additional vials if planning higher doses) - Insulin Syringes:
• 8 wks ≈ 8
• 12 wks ≈ 12
• 16 wks ≈ 16
Consider 50u or 30u syringes if doses require <10 units - Bacteriostatic Water: 1× 30ml
- Alcohol Swabs: 1 box
![Peptide Vial](http://www.dosagepeptide.com/wp-content/uploads/2025/12/Generic-Vial-scaled.png" alt="Cagrilintide + Semaglutide (10mg Blend Vial)" /></div>)
Protocol Overview
A concise summary of this once-weekly regimen.
- Goal: Support weight management and glycemic improvement
- Schedule: Weekly subcutaneous injections for 8–16 weeks or longer
- Dose Range: 0.25 mg to 2.4 mg per week, with a gradual or accelerated ramp-up
- Reconstitution: Use 3 mL for easy measuring (~3.33 mg/mL)
- Storage: Freeze lyophilized vials; refrigerate reconstituted solution
Dosing Protocol
Suggested once-weekly injection schedule that can be tapered up for higher dosing needs.
- Weekly Dose: Start at 0.25 mg or 0.5 mg; escalate as tolerated
- Frequency: Inject once per week subcutaneously
- Cycle Length: 8–16 weeks or more, depending on goals
- Maximum Dose: Typically 2.4 mg weekly for maintenance
- Timing: Any time of day; keep it consistent weekly
Storage Instructions
Proper storage ensures peptide integrity.
- Lyophilized: Freeze until mixing (−20°C)
- Reconstituted: Refrigerate at 2–8°C
- Use within 30 days of reconstitution
- Avoid repeated freeze-thaw cycles
Important Notes
Practical tips to enhance safety and efficacy.
- Always use new, sterile insulin syringes & rotate injection sites.
- Maintain consistency; weekly injections yield the best results.
- Monitor for adverse reactions; consult a professional if concerns arise.
- Track progress and adjust dosage as recommended based on tolerability.
How This Works
Cagrilintide + Semaglutide combines dual pathways for appetite control and metabolic enhancement.
- Hormone Interaction: Agonizes multiple receptors to reduce food intake
- Glycemic Support: Helps regulate insulin secretion and blood glucose levels
- Targets key hormonal signals for improved weight management and satiety
Potential Benefits & Side Effects
Research suggests notable benefits, with considerations for mild GI effects.
- Supports weight reduction and improved metabolic markers
- May enhance glucose control in certain populations
- Common side effects: mild nausea, GI discomfort, or reduced appetite
- Rare side effects: injection-site irritation, headaches
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Clean the vial stopper and skin with alcohol; allow to dry[5].
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[5][6].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[7].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[5][6].
- Do not rub the injection site; apply light pressure with gauze if needed.
Lifestyle Factors
Complementary habits can amplify results.
- Maintain a protein-rich, balanced diet
- Regular physical activity and adequate recovery
- Prioritize sleep and stress management
Recommended Source
We recommend Pure Lab Peptides for high-purity 5-Amino-1MQ (10 mg).
Why Pure Lab Peptides?
- Start: 150 mcg daily for 2 weeks to assess tolerance.
- Mid-Phase: Increase to 300 mcg daily for weeks 3–4.
- Target: 600 mcg daily by weeks 5–8.
- Frequency: Once per day (subcutaneous).
- Cycle Length: 8 weeks minimum; may extend based on research goals.
- Timing: Any consistent time; rotate injection sites.